Emerging Growth News
Boston’s newest public company, Albireo, aims to treat kids’ liver diseases
|
The company announced today that it's going public through a reverse merger with a 13-year-old drugmaker from Danbury, Connecticut called Biodel ...
Growth Capitalist (https://growthcapitalist.com/author/bgoets/page/17/)
The company announced today that it's going public through a reverse merger with a 13-year-old drugmaker from Danbury, Connecticut called Biodel ...
Hitting the $1.10 price point following a recent trading session, shares of Lucas Energy, Inc., Prior to Reverse Merger with Working Interests in ...
Boston biotech Albireo Pharma Inc. went public Thursday through a reverse merger in which it acquired the stock listing of a Connecticut company, ...
Lucas Energy, Inc., Prior to Reverse Merger with Working Interests in Producing Properties and Unde (NYSE:LEI) shares moved to $1.04 after starting ...